Health equipment supplier Viet My Hospital incurs heavier loss in H1

Viet My Hospital Investment JSC, a medical equipment provider, incurred VND4.8 billion ($195,120) in net loss in the first half of this year, widening from a loss of VND4.3 billion ($174,800) in the same period last year.

The business recorded losses of VND1.4 billion ($57,000) in 2023 and VND14.4 billion in ($585,370) in 2021. It posted a net profit of VND3.84 billion ($156,100) in 2022.

As of end-June, the firm posted total assets of VND410.4 billion ($16.68 million), down 8.5% from the start of 2024. Its owner’ equity decreased 1.72% to VND285 billion ($11.6 million) and liabilities declined 20.9% to VND125.4 billion ($5.1 million). Its corporate bond debt stood at VND125 billion.

According to data from the Hanoi Stock Exchange (HNX), Viet My Hospital Investment JSC currently has a single bond batch, BVVM.BOND.2021, issued on January 7, 2021 with a total value of VND200 billion ($8.13 million). It will mature on January 7, 2026.

Founded in 2017 with an initial charter capital of VND300 billion ($12.2 million), Viet My Hospital Investment JSC used to be 98% held by Vietnamese firm Japan Kanpeki JSC, 1% by Le Duc Khanh, and 1% by Nguyen Thi Quynh Anh.

Hanoi-based Japan Kanpeki has a charter capital of VND200 billion ($8.13 million) and once had Nguyen Phuong Hanh as its director and legal representative.

Hanh is related to Dang Nhi Nuong, chairwoman of the American Vietnamese Biotech Inc., also known as Amvi Biotech Inc. (HNX: AMV). In mid-2017, AMV acquired 25 million shares or an 83.33% stake of Viet My Hospital Investment JSC. Since then, AMV remains the parent company of Viet My Hospital.